Showing 1,201 - 1,220 results of 31,612 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (nn decrease)) ))', query time: 0.88s Refine Results
  1. 1201
  2. 1202
  3. 1203
  4. 1204
  5. 1205

    MTT assay shows that the cells exposed to periostin siRNA showed a significant decrease in IC50 among the DDP, EPI, and DTX compared with the control siRNA group (control group) (<i>P</i><0.01). by Dongyang Xu (303547)

    Published 2013
    “…<p>MTT assay shows that the cells exposed to periostin siRNA showed a significant decrease in IC50 among the DDP, EPI, and DTX compared with the control siRNA group (control group) (<i>P</i><0.01).…”
  6. 1206
  7. 1207
  8. 1208

    siRNA mediated knockdown of hZNF-134 decreased the viral transcript levels and the final viral titer output measured by p24 ELISA. by Ronald Benjamin (440573)

    Published 2014
    “…Scrambled siRNA was used as a control. 50picomoles of each siRNA were used. …”
  9. 1209
  10. 1210

    CRISPR/Cas9-mediated deletion of <i>c-REL</i> results in a decreased proliferation of HeLa Kyoto cell accompanied by strongly reduced amounts of histone H2B. by Carsten Slotta (4326091)

    Published 2017
    “…<b>C:</b> Flow cytometric analysis of Annexin V-stained <i>c-REL</i><sup>-/-</sup> and wt HeLa Kyoto cells revealed only slightly increased amounts of apoptotic cells upon <i>c</i>-REL deletion in comparison to wt. …”
  11. 1211
  12. 1212
  13. 1213
  14. 1214

    A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

    Published 2015
    “…The <i>ATP1A1</i> promoter containing the 12T-insertion exhibited decreased transcriptional activity in in vitro reporter-assay systems, indicating decreased α1Na,K-ATPase expression with the 12T-insertion, compared with the 12T-deletion <i>ATP1A1</i> promoter. …”
  15. 1215
  16. 1216
  17. 1217
  18. 1218
  19. 1219
  20. 1220

    The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years. by Regina C. R. M. Abdulkader (302450)

    Published 2017
    “…Metabolic syndrome: presence of at least three of the following criteria: a waist circumference ≥90 cm for men or ≥80 cm for women, triglycerides ≥150 mg/dL, an HDL cholesterol ≤40 mg/dL for males or ≤50 mg/dL for females, a systolic blood pressure ≥130 mm Hg or a diastolic blood pressure ≥85 mmHg and a fasting plasma glucose ≥100 mg/dL. …”